From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting
暂无分享,去创建一个
E. Lipson | W. Sharfman | K. Bleich | Brandon S. Luber | S. Rowe | D. Edelstein | F. Jones | M. Schollenberger | P. Brothers | H. Quinn | Monique Makell | JoAnn Santmyer